ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ADCT ADC Therapeutics SA

4.84
0.08 (1.68%)
Last Updated: 12:06:50
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
ADC Therapeutics SA ADCT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.08 1.68% 4.84 12:06:50
Open Price Low Price High Price Close Price Prev Close
4.76 4.71 4.92 4.76
more quote information »

Recent News

Date Time Source Heading
4/04/202407:00GLOBEADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial..
4/03/202407:00GLOBEADC Therapeutics to Host a Virtual Research Investor Event..
4/01/202416:05GLOBEADC Therapeutics Makes Grants to New Employees Under..
3/13/202407:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
3/13/202407:00GLOBEADC Therapeutics Reports Fourth Quarter and Full Year 2023..
3/06/202407:15GLOBEADC Therapeutics to Participate in the Guggenheim 5th Annual..
3/06/202407:00GLOBEADC Therapeutics to Host Fourth Quarter and Year-End 2023..
3/05/202417:45GLOBEADC Therapeutics Announces Abstracts Accepted for..
3/05/202409:15EDGAR2Form 8-K - Current report
2/29/202416:30EDGAR2Form 8-K - Current report
2/27/202407:00GLOBEADC Therapeutics to Participate in the TD Cowen 44th Annual..
1/24/202408:00EDGAR2Form 8-K - Current report
1/19/202416:30EDGAR2Form 8-K - Current report
1/04/202407:15EDGAR2Form 8-K - Current report
1/04/202407:15GLOBEADC Therapeutics Regains Compliance with NYSE Continued..
1/04/202407:00EDGAR2Form 8-K - Current report
1/04/202407:00GLOBEADC Therapeutics Provides Business Updates
1/02/202420:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202420:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202420:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202420:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202419:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202419:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/19/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/18/202316:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/12/202305:15GLOBEADC Therapeutics Announces Initial Results from..
12/04/202316:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/20/202302:40PRNUSSobi to present new data at ASH 2023 Annual Meeting
11/15/202303:00GLOBEMyricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur..
11/07/202307:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202307:15GLOBEADC Therapeutics Receives NYSE Notice of Non-Compliance With..
11/07/202307:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202307:00GLOBEADC Therapeutics Reports Third Quarter 2023 Financial..
11/06/202307:00GLOBEADC Therapeutics to Participate in the Jefferies London..
11/02/202310:10GLOBEADC Therapeutics Announces Abstracts Accepted for..
10/24/202307:00GLOBEADC Therapeutics to Host Third Quarter 2023 Financial..
10/04/202304:00GLOBEMyricx Expands its ADC Expertise with the Appointment of..
9/11/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/05/202307:00GLOBEADC Therapeutics to Participate in September Investor..
8/30/202319:32GLOBEADC Therapeutics Announces Updates on ZYNLONTA® LOTIS..
8/08/202307:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/08/202307:00GLOBEADC Therapeutics Reports Second Quarter 2023 Financial..
8/01/202307:00GLOBEADC Therapeutics to Host Second Quarter 2023 Financial..
7/24/202307:21GLOBEOverland ADCT BioPharma Announces NMPA Accepts Biologics..
7/20/202316:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/20/202316:05GLOBEADC Therapeutics Announces Plan to Discontinue the Phase 2..
7/11/202309:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/11/202307:00GLOBEADC Therapeutics Announces Voluntary Pause of Enrollment in..
6/15/202307:15GLOBEADC Therapeutics Announces Evolution of Board of Directors
6/09/202307:15GLOBEADC Therapeutics Announces Updated LOTIS-2 Results..

Your Recent History

Delayed Upgrade Clock